UC Health Transplant is proud to announce the 2014 Hepatocellular Carcinoma Symposium: Advances and Challenges for a Rapidly Increasing Malignancy. This event will take place on Saturday, September 27, 2014, from 7:30 a.m. – 3:30 p.m. at the Daniel Drake Center for Post-Acute Care.
This event is intended for area Hematologists, Oncologists, Surgical Oncologists, Biliary Oncologists, Radiologists, Hepatologists, Gastroenterologists, Gastrointestinal and Biliary Surgeons, Transplant Physicians and Surgeons, Mid-Level Providers, and Nurses.
Conference Objectives
- Upon completion of this course, the participantshould be able to:
- Diagnose and treat Hepatocellular Carcinoma
- Describe the benefits – pros and cons of resection versus transplantation
- Recognize limitations of therapies directed at Hepatocellular Carcinoma including chemotherapy, catheter directed therapy, resection, ablation and liver transplantation
- Explain new approaches to the management of Hepatocellular Carcinoma in cirrhotic patients
Keynote Speaker:
Francis Y.K. Yao, MD
University of California San Francisco
Professor of Clinical Medicine and Surgery
Medical Director, Liver Transplant Service
Director for Community Liaison, Liver Transplant Service
Conference Faculty:
Shimul A. Shah, MD, MHCM
University of Cincinnati Associate Professor of Surgery
Director, Liver Transplantation and Hepatobiliary Surgery
Nadeem Anwar, MD
University of Cincinnati Associate Professor of Clinical Medicine
Medical Director, Liver Transplantation
For more information or to register, click here.
